deepeye Medical

About

100+ million people globally suffer from vision-threatening retinal diseases. A $13bn drug can stop patients from vision loss. Still, ⅔ of cases of blindness in EU+US are due to these diseases like wet AMD. We provide an AI-based precision health platform that emulates a proven clinical method. This method used 2nd expert opinion for eye doctors to achieve 6x(!) better therapy results across thousands of patients: - Improving real-world vision outcomes by 3x (36% > 100%) - Keeping 2x more patients in therapy (38% > 78%) Our big vision is to prevent 1 million additional people from blindness by 2030 by empowering ophthalmologists with AI-based optimal therapy prognosis. Our pre-clinical AI is used by pharma, payors and providers’ associations to gain new insights on their therapy data. We work on our clinical product to provide therapy decision support with 1 click at the PoC in 2024.